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Abstract
The Acute respiratory distress syndrome (ARDS) is a highly lethal inflammatory lung disorder. Apoptosis plays a key role in
its pathogenesis. We showed that an adenovirus expressing the 70 kDa heat shock protein Hsp70 (AdHSP) protected
against sepsis-induced lung injury. In this study we tested the hypothesis that AdHSP attenuates apoptosis in sepsis-
induced lung injury. Sepsis was induced in rats via cecal ligation and double puncture (2CLP). At the time of 2CLP PBS,
AdHSP or AdGFP (an adenoviral vector expressing green fluorescent protein) were injected into the tracheas of septic rats.
48 hours later, lungs were isolated. One lung was fixed for TUNEL staining and immunohistochemistry. The other was
homogenized to isolate cytosolic and nuclear protein. Immunoblotting, gel filtration and co-immunoprecipitation were
performed in these extracts. In separate experiments MLE-12 cells were incubated with medium, AdHSP or AdGFP. Cells
were stimulated with TNFa. Cytosolic and nuclear proteins were isolated. These were subjected to immunoblotting, co-
immunoprecipitation and a caspase-3 activity assay. TUNEL assay demonstrated that AdHSP reduced alveolar cell
apoptosis. This was confirmed by immunohistochemical detection of caspase 3 abundance. In lung isolated from septic
animals, immunoblotting, co-immunoprecipitation and gel filtration studies revealed an increase in cytoplasmic complexes
containing caspases 3, 8 and 9. AdHSP disrupted these complexes. We propose that Hsp70 impairs apoptotic cellular
pathways via interactions with caspases. Disruption of large complexes resulted in stabilization of lower molecular weight
complexes, thereby, reducing nuclear caspase-3. Prevention of apoptosis in lung injury may preserve alveolar cells and aid
in recovery.
Citation: Aschkenasy G, Bromberg Z, Raj N, Deutschman CS, Weiss YG (2011) Enhanced Hsp70 Expression Protects against Acute Lung Injury by Modulating
Apoptotic Pathways. PLoS ONE 6(11): e26956. doi:10.1371/journal.pone.0026956
Editor: Marcelo G. Bonini, University of Illinois at Chicago, United States of America
Received October 17, 2010; Accepted October 7, 2011; Published November 23, 2011
Copyright:  2011 Aschkenasy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants from the Israel Science Foundation (#586/03 and # 529_/08 - YGW), the Israel Ministry of Health Chief
Scientist (#5304 - YGW), the NIH/NIGMS (GM059930-07 - CSD) and the Stavropoulos Sepsis Research Program (CSD). No additional external funding was received
for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: weiss@hadassah.org.il
. These authors contributed equally to this work.
Introduction
The Acute Respiratory Distress Syndrome (ARDS) is a lethal,
incompletely understood syndrome that frequently accompanies
sepsis [1,2]. The initial phase of the disorder involves unchecked
inflammation that damages and may destroy type I alveolar
epithelial cells [2,3,4]. While the exact mechanisms that lead to
pulmonary cell death are unknown, it is likely that apoptosis plays
an important pathogenic role [5,6].
Normally, apoptosis is a homeostatic response to eliminate
damaged or senescent cells [7,8,9]. This form of regulated cell
death may be induced by a range of environmental, physical or
chemical stresses [10]. Activation of apoptosis depends on a pro-
teolytic system that involves some members of a family of intra-
cellular enzymes called caspases. Several, such as caspase-3, -8 and
-9, initiate and execute the cell death process while others have
been implicated in inflammation [11,12,13]. Caspases are present
in the cell in a precursor state. Following a pro-apoptotic signal,
these pro-caspases are cleaved to yield the activated enzymes.
Activation and progression of apoptosis is tightly controlled.
Part of the regulatory system involves Heat Shock Proteins (HSPs).
These molecular chaperones are expressed both constitutively and
in response to cellular and extracellular perturbations [14,15]. As a
result, they are involved in a myriad of normal homeostatic
processes and can mediate cellular protection and recovery [16].
The involvement of HSPs in such a wide range of cellular activities
reflects the ability of these molecules to interact with hydrophobic
regions of nearly all proteins or polypeptides. Among HSPs,
members of the 70 kDa subfamily, collectively referred to as
Hsp70, are phylogenetically conserved, highly inducible and
believed to play an essential role in normal cell processes and in
the response to noxious stimuli [17].
Previously, we have demonstrated that intra-tracheal adminis-
tration of an adenoviral vector that expresses Hsp70 (AdHSP)
attenuates lung pathology and improves outcome in lung injury
induced by cecal ligation and double puncture (2CLP) in rats
[18,19,20]. In this model, AdHSP limited histologic lung injury,
attenuated acute inflammation and neutrophil recruitment by
suppression of NF-kB activation [21], limited over-proliferation of
type II pneumocytes [22] and preserved type I alveolar epithelial
cells [20]. This last finding may be related to altered apop-
tosis. Indeed, others have established that Hsp70 can attenuate
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procaspase-9 to the Apaf-1 apoptosome, a complex composed of
cytochrome C, oligomerized Apaf-1 and pro-caspase 9 [23].
Therefore, the studies outlined in this paper tested the hypo-
thesis that AdHSP-induced expression of Hsp70 protects the lung
from sepsis-induced injury in part by attenuating pro-apoptotic
processes.
Results
AdHSP reduces apoptosis in 2CLP induced lung injury
Previous publications investigating ARDS have demonstrated
an association between inflammation and apoptosis [24]. In
addition, we have shown that 2CLP-induced lung injury is
associated with a loss of type I pulmonary epithelial (ATI) cells
[20,22]. Therefore, we used the TUNEL assay to test the
hypothesis that treatment with AdHSP attenuated 2CLP-induced
lung injury and apoptosis in these cells. Relative to normal, non-
septic controls (T0), TUNEL staining (green fluorescence) was
increased in PBS-treated (2CLP-PBS) (P,0.01) as well as in
AdGFP-treated (2CLPAdGFP) rats. In contrast, lungs from septic
rats treated with AdHSP had significantly less TUNEL staining
than PBS (Fig. 1).
Under normal conditions the great majority of cells in the lung
are type I pulmonary epithelial cells or endothelial cells. In ARDS,
the normal cellular composition is altered by the infiltration of a
large number of neutrophils. Thus, the enhanced TUNEL staining
might reflect apoptosis in these inflammatory cells. To investigate
this possibility and to strengthen our demonstration of an inflam-
matory process in 2CLP treated animals, Myeloperoxidase (MPO)
immunostaining was performed. Data depict the presence of an
increased number of neutrophils in the alveolar spaces of PBS-
treated, as opposed to AdHSP-treated animals (Fig. 2A). Co-
staining (Fig. 2B) for MPO (brown stain on left panel) and TUNEL
(green stain on right panel) demonstrated that some of the
TUNEL-positive cells were neutrophils (MPO positive, TUNEL
positive, white arrows). However, most neutrophils (MPO positive,
TUNEL negative, black arrows) were not apoptotic. In contrast, a
number of cells (Fig. 2B, MPO negative, TUNEL positive, yellow
arrows) were TUNEL positive but MPO negative. This indicates
Figure 1. AdHSP reduces apoptosis in 2CLP induced ARDS. Representative TUNEL-stained fixed tissue section. Positive staining depicted in
green. T0 - Untreated controls, 2CLPPBS - septic animals treated with PBS, 2CLPAdHSP - septic animals treated with AdHSP, 2CLPAdGFP – septic
animals treated with AdGFP. Nuclei stained with DAPI. Upper panel:2 0 6magnification, lower panel:4 0 6magnification. Positive control - DNAse
treatment. Graph – Graphic representation of fluorescent nuclei/low powered field. Quantification performed on 20 lung fields/slide at 206
magnification, five slides per animal and at least 3 animals for each intervention. Quantification of TUNEL staining was performed using Nikon
software. 20 fields per slide were randomly manually selected by a single observer who was blinded to the intervention (AdHSP, AdGFP, PBS). Data
are mean +/2 standard deviation *=significantly different from T0 and AdHSP.
doi:10.1371/journal.pone.0026956.g001
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apoptosis seen in untreated experimental lung injury. Double
immunostaining to aquaporin-5 (AQP5), a key alveolar type I
surface marker (20,22) and TUNEL, demonstrated that most of
the apoptotosis (TUNEL positive, green fluorescence) occurred in
alveolar type I (AQP5 positive, brown staining, red arrows) and
type II (yellow arrows) (Fig. 2C). Thus, 2CLP-induced pulmonary
apoptosis predominantly occurs in type I and type II alveolar
epithelial cells and not in neutrophils.
AdHSP reduces the abundance of Caspase 9 and Caspase
8 in 2CLP-induced lung injury
Others have shown that Hsp70 affects the apoptosome [25].
However, the effects of Hsp70 on other pro-apoptotic enzymatic
complexes have not been fully explored. Studies indicate that
apoptosis initiated by an extracellular signal requires activation of
caspase 8 while the mitochondrial pathway proceeds via caspase 9
[13]. Data examining the effects of AdHSP on the apoptotic
cellular pathway during 2CLP-induced lung injury are presented
in Fig. 3. Immunoblotting revealed that, relative to untreated
controls (T0), treatment of with PBS or AdGFP increased the
abundance of activated caspase 8 (upper panel) and caspase 9
(middle panel) in rat lung cytosolic extracts isolated 48 hrs after
2CLP (Fig. 3A). However, in extracts isolated 48 hours after 2CLP
from rats treated with AdHSP, the cytosolic abundance of
activated caspases 8 and 9 in the lungs was significantly lower
than that observed in isolates obtained from similar animals
treated with PBS or AdGFP (P,0.049, P,0.041 respectively).
Protein of the anti-apoptotic Bcl2 family play a key role in
the regulation of mitochondria/apoptosome-dependent apoptosis
[26]. To determine the effects of AdHSP on 2CLP-induced
changes in Bcl2, we examined the mitochondrial Bcl2 abundance
(Fig. 3A, lower panel). These data reveal preserved levels of Bcl2 in
T0 and 2CLPAdHSP animals. However, treatment of 2CLP
animals with PBS or AdGFP significantly reduced Bcl2 abun-
dance. These data suggest that AdHSP exerts its effect, in part, by
preserving Bcl2.
Hsp70 disrupts the normal apoptotic signaling Apaf-1
An important study by Saleh et al [25] demonstrated that the
anti-apoptotic effect of Hsp70 was mediated via a direct
association with the caspase-recruitment domain of Apaf-1. This
prevented the oligomerization of Apaf-1, the subsequent associ-
ation of Apaf-1 with pro-caspase 9 and ultimately apoptosome
Figure 2. AdHSP reduces Myeloperoxidase (MPO) in 2CLP-induced lung injury. A. Myeloperoxidase (MPO) immunostaining. 206
Magnification. MPO containing cells stain brown. Left panel: 2CLPAdHSP, Right panel: 2CLPPBS. TUNEL and MPO double staining. 406
Magnification. Left panel: Myeloperoxidase (MPO) Immunostaining, MPO containing cells stain brown. Right panel: TUNEL fluorescent staining.
TUNEL positive cells are green. White arrows depict apoptotic neutrophils – brown staining for MPO and green for TUNEL. Yellow arrows depict
apoptotic cells that are negative for MPO but positive for TUNEL. Red arrows depict nuclei stained for dapi –showing the orientation of the slide.
Black arrows depict MPO-positive cells that were not apoptotic. TUNEL and Aquaporin 5 (AQP5) double staining. AQP5 – a specific marker for alveolar
type I cells. 406magnification. Left panel: AQP5 immunostaining, AQP5 containing cell stain brown. Right panel: TUNEL fluorescent staining. TUNEL
positive cells are green. Red arrows indicate positive staining of alveolar type I cells (both AQP5 and TUNEL). Yellow arrows indicate alveolar type II
cells that are negatively stained for AQP5 and positively stained for TUNEL.
doi:10.1371/journal.pone.0026956.g002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e26956Figure 3. AdHSP reduces the abundance of caspases 8 and 9 in 2CLP-induced lung injury. A. Immunoblotting of whole cytosolic extracts
for Caspase 8 and 9. Abbreviations as in Fig. 1. Upper panel: Representative autoradiogram of SDS-PAGE, 30 mg of cytosolic extract/lane. Primary
rabbit polyclonal antibody to caspase 8. Secondary goat anti rabbit IgG. .Graphic representation of relative density of cytosolic caspase 8. Middle
panel: Representative autoradiogram of SDS-PAGE, 30 mg of cytosolic extracts. Primary rabbit polyclonal antibody to caspase 9, secondary goat anti
rabbit IgG. Graph - Graphic representation of relative density (mean +/2 standard deviation) of cytosolic caspase 9. *=significantly different from
2CLPPBS and 2CLPAdGFP. Lower panels: Representative autoradiogram of SDS-PAGE, 30 mg of mitochondrial extract/lane. Primary mouse
monoclonal antibody to Bcl2, secondary goat anti mouse IgG and primary mouse monoclonal antibody to COX IV, secondary goat anti mouse IgG.
COX IV serves as mitochondrial loading control. B. Hsp70 in vivo interaction with apopotosomal Apaf-1. Representative autoradiograms.
Samples were immunoprecipitated with a rabbit polyclonal antibody to Apaf-1 and subjected to SDS-PAGE. Upper panels: Immunoblotting with a
primary rabbit polyclonal antibody to pro-caspase 9, secondary goat anti rabbit IgG. Middle panels: Immunoblotting with primary mouse monoclonal
antibody to Hsp70, secondary goat anti mouse IgG. Lower panels: IgG detection IgG serves as loading control. 250 mg of cytosolic extracts obtained
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prevented the recruitment of pro-caspase-9 to the Apaf-1
apoptosome [23]. These effects on caspase recruitment and
apoptosome formation might be involved in Hsp70-mediated
effects on sepsis-induced lung injury. Therefore, we examined the
effects of AdHSP on the interaction between Apaf-1 and pro-
caspase-9 in lung following 2CLP. Lung extracts were immuno-
precipitated with an antibody directed at Apaf-1 and subjected to
immunoblotting with an antibody to pro-caspase 9. Data are
displayed in Fig. 3B. No interaction was noted in non-septic,
untreated animals (T0). In septic animals treated with PBS,
immunoblotting revealed a strong association between Apaf-1 and
pro-caspase-9 (2CLPPBS). Similar results were observed in
animals treated with AdGFP (2CLPAdGFP) However, this
interaction was markedly reduced in animals treated with AdHSP
(2CLPAdHSP). To strengthen our contention that these findings
were likely specific to alveolar epithelial cells and not other cells
types present in lung extracts, we performed in-vitro experiments
where we stimulated MLE-12 cells (Type II pneumocyte analogs)
with tumor necrosis factor (TNF). These cell cultured extracts
were immunoprecipitated with anti-Apaf-1 and immunoblotting
with an antibody to pro-caspase-9 was performed. Data are
depicted in Fig. 3C. In cells treated with TNF alone (MLE+TNF),
or with AdGFP and TNF stimulation (MLE+TNF+AdGFP) there
is an association between Apaf-1 and pro-caspase 9. No Hsp70
was noted. When cells were incubated with AdHSP and then
subjected to TNF stimulation (MLE+AdHSP+TNF) we found
an association between Apaf-1 and Hsp70 but a less robust
association of Apaf-1 with pro-caspase 9. However, similar
experiments involving immunoblotting with an antibody to
caspase-8 failed to demonstrate an interaction between Apaf-1
and caspase 8 (data not shown).
The apoptosome is a large (approximately 700–1400 kDa),
caspase-activating complex that is assembled from Apaf-1 and
caspase-9 when cytochrome c is released during mitochondrial-
dependent apoptotic cell death. Apaf-1, the core scaffold protein,
is approximately 135 kDa and contains a caspase recruitment
domain (CARD) [27]. To examine the effects of AdHSP, we
incubated GST-Apaf-1-CARD obtained from BL-21 cells, Cyto-
chrome C and ATP, with immunopercipitated pro-caspase 9
isolated from 2CLPPBS and 2CLPAdHSP treated Lungs. Data
depicted in Fig. 3D reveal increased cleaved casapase 9 production
after the first five minutes of incubation in 2CLPPBS animals. In
contrast, 2CLPAdHSP animals depict a decrease in cleaved
caspase 9 production.
AdHSP attenuates the expression of inactive and active
caspase-3 in 2CLP-induced lung injury
Activation of caspase 3 is the terminal step in the apoptotic
cascade and the main executioner of apoptosis [28]. The process
involves cleavage of pro-caspase 3. This in turn is facilitated by
interaction of the uncleaved, inactive pro-caspase-3 with either
caspase-8 or caspase 9 that has been activated by the apoptosome.
Association permits cleavage of pro-caspase-3 and nuclear
transmigration of the now activated caspase-3. We sought to
determine if 2CLP activated pro-caspase 3 cleavage and to
examine the effects of Hsp70 on this process. Therefore we
investigated the effects of AdHSP on 2CLP-induced changes in the
cytosolic abundance of uncleaved (inactive) pro-caspase-3 and the
intranuclear abundance of cleaved (active) caspase-3. Lung ho-
mogenate fractions were obtained from rats subjected to 2CLP
and treated with either PBS (2CLPPBS), AdGFP (2CLPAdGFP)
or AdHSP (2CLPAdHSP). Data are depicted in Fig. 4. 2CLP
increased the abundance of pro-caspase-3 in the cytosol (Fig. 4a,
upper panel) and cleaved caspase-3 in the nucleus (Fig. 4a, lower
panel) of animals treated with PBS or AdGFP. In contrast, neither
was increased in animals subjected to 2CLP and treated with
AdHSP (Fig. 4a). To confirm these findings we immunostained
lung sections with an antibody to cleaved caspase-3 (Fig. 4B).
Relative to T0, caspase 3 staining increased in the nuclei of cells
in sections obtained from septic animals treated with PBS
(2CLPPBS). There was little staining, however, in rats treated
with AdHSP at the time of 2CLP (2CLPAdHSP). The 6100
magnification depicts the nuclear staining (Fig. 4B Lower panel).
The amount of staining is depicted at lower magnification (Fig. 4B
Upper panel). These findings further substantiate the ability of
Hsp70 to attenuate caspase-3 cleavage and nuclear translocation
and thus activation. To further solidify our findings we measured
Caspase-3 activity directly in TNF – activated MLE-12 cells
(Fig. 4c). These data indicate that cytoplasmic caspase-3 activity
was decreased by AdHSP treatment. Unfortunately, it was not
possible to measure caspase-3 activity in lung extracts in – vivo
because of the lack of a specific assay kit for homogenates/tissues.
Multiple effects of AdHSP on 2CLP-induced caspase
complexes - disruption and stabilization
In a previous paper we have shown that over-expression of
Hsp70 disrupted large molecular weight complexes [21]. The
same effect may limit the formation of large active molecular
weight complexes associated with the apoptotic pathway. Caspase
3 is activated by either caspase 8 (extrinsic pathway) or caspase 9
(intrinsic/mitochondrial pathway). In either pathway, in vitro
studies have demonstrated that caspase 3 forms a complex with
the activating protease [29]. However, this finding has not been
confirmed in complex in vivo situations such as sepsis-induced lung
injury. Therefore we used co-immunoprecipitation and immuno-
blotting to examine the effects of AdHSP on the sepsis-induced
formation of complexes containing pro-caspase 3, caspase 8 and
caspase 9, as well as Apaf-1. Cytosolic lung extracts obtained
48 hrs after 2CLP were immunoprecipitated with an antibody to
caspase-9 and subjected to immunoblotting with antibodies to
caspases-8, 9, 3 and Apaf-1 (Fig. 5). These data revealed the
previously reported interactions between caspases-8 and -3 and
caspases-9 and -3 as well as an unexpected and previously
unreported cytosolic interaction between caspases-8 and -9
(Fig. 5A,B,C). Immunoprecipitation of samples with an antibody
from TO, 2CLPPBS, 2CLPAdHSP or 2CLPAdGFP treated animals sacrificed 48 hrs after the induction of sepsis. C. Hsp70 in vitro, MLE-12 cells,
interaction with apopotosomal Apaf-1. Representative autoradiograms. 250 mg of cytosolic extracts obtained from non treated MLE-12 cells
(controls), stimulated with tumor necrosis factor (TNF) and treated with AdHSP or AdGFP. Samples were immunoprecipitated with a rabbit polyclonal
antibody to Apaf-1 and subjected to SDS-PAGE. Upper panels: Immunoblotting with a primary rabbit polyclonal antibody to pro-caspase 9, secondary
goat anti rabbit IgG. Middle panels: Immunoblotting with primary mouse monoclonal antibody to Hsp70, secondary goat anti mouse IgG. Lower
panels: IgG serves as loading control. D. Apaf-1 – CARD dissociates from Pro-caspase-9 in the presence of Hsp70. Representative
autoradiograms. 100 mg of cytosolic extracts obtained from 2CLPPBS and 2CLAdHSP treated animals, were immunoprecipitated with Pro-caspase-9
and further incubated with GST-Apaf-1 – CARD obtained from BL-21 cells, together with 5 mM ATP and 5 mg/ml human Cytochrome C for 5, 10, 20
and 30 minutes. Samples were subjected to SDS-PAGE, immunoblotted and the membranes were incubated with primary rabbit polyclonal antibody
to Cleaved Caspase-9, secondary to goat anti rabbit IgG.
doi:10.1371/journal.pone.0026956.g003
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caspase-9 and, conversely, immunoprecipitation with and anti-
body to caspase 9 followed by immunoblotting with anti- caspase 8
confirmed this finding (Fig. 5A,B).
Treatment with AdHSP significantly altered this association
between caspase 8 and caspase 9. Similar effects were found in
TNF-activated MLE-12 and A549 cells (Fig. 5A). Further, an
association between caspase 8 and caspase 9 was detected in 2CLP
lungs in-vivo. (Fig. 5B).
To further investigate the effect of AdHSP on the association
between these enzymes, we immunoprecipitated cell homogenates
with an antibody to caspase 9 and performed fractionation by
molecular weight (gel filtration) followed by immunoblotting.
These studies (Fig. 5C) revealed that the interaction between
caspases 8 and 9 found in PBS-treated septic rats (2CLPPBS)
occurred in complexes with molecular weights between 400–
600 kDa that contained little caspase 3 or Hsp-70. Treatment with
AdHSP disrupted the caspase 8–9 interaction and shifted caspase-
9 abundance to smaller (100–400 kDa) complexes that contained
Hsp70 and Caspase-3 as well as a more limited amount of caspase
8. Finally, an Apaf-1/caspase-9 complex, shifted from the
1500–900 kDa fraction in 2CLPPBS to the 600–400 kDa in the
2CLPADHSP fraction. These data are consistent with an Hsp70-
mediated stabilization of low molecular weight cytosolic complexes
containing primarily caspase 9 as well as varying amounts of
caspase 3 and Hsp70. This is similar to and effect on NF-kB
complexes that we have reported previously [21,22].
Discussion
Our previous studies have demonstrated that AdHSP-induced
augmentation of Hsp70 abundance protects against sepsis-induced
acute lung injury [19]. Our subsequent work has sought to identify
the mechanisms by which the attenuation of pulmonary damage
might occur and to examine the therapeutic role of Hsp70. These
data have revealed that AdHSP interferes with the activation of
the pro-inflammatory transcription factor NF-kB [21] and limits
division of type II pulmonary epithelial cells [22]. Enhanced
apoptosis also has been implicated in the development of acute
lung injury. Others have demonstrated that Hsp70 attenuates
Figure 4. AdHSP prevents nuclear translocation of activated Caspase-3. A. Representative autoradiograms for pro-caspase 3 and activated
(cleaved) Caspase 3. 30 mg of cytosolic (upper panels) and nuclear (lower panel) extracts were subjected to SDS-PAGE. Immunoblotting performed
with primary rabbit polyclonal antibody to pro- caspase 3 and secondary goat anti rabbit IgG, primary goat antibody to b-actin and secondary
donkey anti goat IgG, primary rabbit polyclonal antibody to active (cleaved) caspase-3 and secondary goat anti rabbit IgG, primary mouse
monoclonal antibody to histone (H1) and secondary goat anti mouse IgG. b-actin and histone serve as loading controls. B. Representative stained
fixed tissue section depicting intra-nuclear staining for Caspase 3. Sections obtained from T0 control, 2CLPPBS and 2CLPHSP rats. Tissue
isolated 48 hrs after the induction of sepsis. Upper panel:4 0 6magnifications. Black arrows indicate active caspase 3 stained nuclei. Lower panel:
1006 magnification of upper panel. C. Caspase 3 Activity Assay. Graphic representation of relative caspase-3 enzymatic activity (mean +/2
standard deviation) *=significantly different from Control and AdHSP+TNF.
doi:10.1371/journal.pone.0026956.g004
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an in vivo model of an acute disease state. Therefore, it is logical to
examine the effects of AdHSP on apoptotic cellular pathways in
our lung injury model.
As expected, lung injury induced by 2CLP increased the
abundance of active caspase 8, active and inactive caspase 9 and
pro-caspase 3. However, treatment with AdHSP attenuated this
activation and decreased the abundance of these enzymes to levels
equal or close to those observed in unoperated, non-septic controls.
This effect is not the result of viral infection, as treatment with
AdGFP, an adenoviral vector expressing the marker green fluorescent
protein, did not affect sepsis-induced apoptosis in pulmonary cells.
Our previous work has demonstrated that Hsp70 alters
inflammation and cell replication in the lungs of septic rats by
associating with key enzymes and effecting protein-protein
interactions within hetero-multimeric complexes [21,22]. Others
have demonstrated that Hsp70 has the capacity to protect certain
caspase substrates by directly binding to caspase-3 and caspase-9
and thereby, promote survival [33].
The experiments described here reveal a similar mechanism.
Specifically, AdHSP alters interactions between caspases 8, 9 and
3. As in previous studies, the experiments detailed here confirm
the multi-faceted nature of these Hsp70-mediated effects. In vivo,
Hsp-70 disrupted the high molecular weight caspase complex and
stabilized caspase 3 in a low molecular complex with caspase 8 and
9. In TNF-treated MLE-12 cells, treatment with AdHSP blocked
activation of caspase-3. AdHSP also limited nuclear translocation
of caspase-3 by stabilizing the caspase 8/9-caspase 3 complex and
preventing caspase-3 activation. We present reduced pro-capase 3
levels in 2CLPAdHSP treated animals. Most papers address
specifically the cleaved caspase 3 without evaluating possible
effects of inflammatory processes on pro-caspase 3 levels. As
shown here (Fig. 4A), also others have shown that pro-caspase 3
levels increase following inflammatory processes such as renal
injury [34] and decrease after caspase-3 siRNA addition within the
injured kidney [35]. We have observed similar differential effects
in Hsp70’s interaction with elements of the NF-kB signaling
pathway [21]. Others investigating apoptosis in septic lung injury
Figure 5. AdHSP alters interactions between Caspase 8, 9, 3 and Apaf-1. A and B: Representative Autoradiogram Demonstrating AdHSP
treatment disrupts interaction between caspase 8 and caspase 9. Representative autoradiograms. 250 mg of cytosolic extracts were
immunoprecipitated with rabbit polyclonal antibody to caspase 8 or caspase-9 and subjected to SDS-PAGE. Immunoblotting performed with
either primary rabbit polyclonal antibodies to caspase 9 or caspase-8, secondary goat anti rabbit IgG. Lower panels: IgG detection. IgG serves as
loading control. Abbreviations as in Figure 1. C: Hsp70 disrupts caspases 3, 8 9 and Apaf-1 complexes. 250 mg of cytosolic extracts from lung
tissue fractionated via column chromatography, eluted by molecular weight, immunoprecipitated with an antibody to caspase-9 and subjected to 9%
SDS-PAGE. Molecular weight of each fraction (kDa) indicated at the top of the figure. Detecting antibodies (anti-caspase 9, anti-caspase 8, anti-pro-
caspase 3, anti-Hsp70 and anti-Apaf-1,) noted to the left of the panels. Lower panel: IgG detection. IgG serves as loading control. Abbreviations as in
Figure 1.
doi:10.1371/journal.pone.0026956.g005
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similarly inhibits polymorphonuclear leukocyte apoptosis by
decreasing caspase-3 activity [36]. In vitro studies also demonstrate
that Hsp70 prevented recruitment of pro-caspase-9 to the Apaf-1
apoptosome [23,25,37]. Furthermore, using GST-Apaf-1-CARD
we demonstrate that Apaf-1-CARD dissociates from pro-caspase 9
in the presence of HSP-70 resulting in reduced production of
caspase 9. Our data confirmed these findings in vivo and ex-vivo.
Finally, the experiments presented here uniquely demonstrate that
Hsp70 impairs protein interactions, in pulmonary epithelial cells,
that effect apoptotic cellular pathways through mechanisms not
directly involving the apoptosome, thus modulating apoptosis in
several independent ways. The relative importance of each of the
observed interactions in mediating the effects of Hsp70 on
apoptosis will require further investigation as will the role of
other, non-Hsp70 effects. Morimoto has pointed that Hsp70-
protein interactions likely are modulated by associated molecules
called co-chaperones [38]. This suggests that Hsp70-protein
interactions may be different in other cell types and under
alternate in vivo conditions.
It is possible that Hsp70 does not disrupt but rather prevents
apoptosome formation. However, we have shown that adenoviral
treatment with a marker protein orwith HSP do not lead to significant
increases in Hsp70 abundance until 16–24 hours after administration
[19,20]. Changes consistent with lung injury are noted as early as
6 hours after 2CLP [20]. Therefore, disruption is more likely.
One important observation from our previous studies involves
stabilization of proteins into complexes that alter activity. Spe-
cifically, our investigations into the proteins involved in the
activation of NF-kB have revealed Hsp70-mediated stabilization
of low molecular weight complexes. These are known to have
lower activity than larger complexes containing more enzymati-
cally active subunits [21]. In the data presented here, we have
uncovered interactions involving several combinations of caspase-
9, 8 and 3 in septic animals treated with PBS. These complexes
appear to have been disrupted by enhanced Hsp70 expression.
Further, as in the NF-kB pathway, AdHSP appears to disrupt high
molecular caspase complexes and to stabilize low-molecular
intermediate complexes. As a result, it is likely that Hsp70
prevents Caspase-3 migration into the nucleus. This suggests one
common mechanism by which Hsp70 alters enzymatic activity.
Further investigations should be directed towards examination of
this possibility.
In summary, the studies detailed here demonstrate Hsp70-
mediated effects on apoptosis. In concert with our previous work
on Hsp70 and the NF-kB inflammatory pathway [21] and on cell
replication [22], they expand our understanding of the mecha-
nisms by which Hsp70 alters cellular processes. Further, they pave
the way for therapeutic use of Hsp70 in the treatment of ARDS, a
common, life-threatening syndrome.
Materials and Methods
Induction of Sepsis
All studies were approved by the Institutional Animal Care and
Use Committees (IACUC) of both collaborating institutions and
conform to both University Laboratory Animal Resources
(ULAR), The Hebrew University School of Medicine ethics
committee – research number MD 109.14-4 and National
Institute of Health standards. Severe sepsis was induced by cecal
ligation and double puncture (2CLP) in male adolescent Sprague-
Dawley rats under isoflurane anesthesia as previously described
[18,19,20,21,22]. Animals were fluid resuscitated (50 cc/kg of
0.9% saline injected subcutaneously) at the time of surgery and at
24 hours. 48 hours after 2CLP animals were euthansized with an
overdose (150 mg/kg) of pentobarbital. As previously described
[18,19,20,21], one lung was removed en bloc, perfused, gently
inflated to a pressure of 20 cm H2O, fixed overnight in 10%
formalin, sagitally sliced and paraffin embedded. Studies were
performed on 5 mm sections. The other lung was homogenized for
extraction of cytoplasmic and nuclear protein.
Adenoviral Vector Administration
As previously described, 10
11 viral plaque-forming units (PFUs)
of either AdHSP or of a recombinant E1,E3-deleted adenoviral
vector expressing Green Fluorescent Protein (AdGFP) dissolved in
PBS (total volume, 300 ml) were administered via tracheal
puncture at the time of 2CLP [18,19]. Administration of a control
vector, AdGFP, was used to provide data on the effects of an
adenoviral vector that did not express HSP70. A second set of
control animals were subjected to 2CLP and treated with
intratracheal PBS alone.
Isolation and Preparation of Cytosolic and Nuclear
Extracts from Lungs
Cytosolic and nuclear proteins were isolated from lung tissue as
previously described [18,19]. Protein concentration was deter-
mined in an aliquot of each lysate using the Bradford method (Bio-
Rad laboratories, GmbH, Manheim, Germany).
Cell culture
MLE (murine lung epithelial)-12 cells and A549 lung carcinoma
cells (ATCC, Manassas, VA, USA) were grown to confluence in
Hites or RPMI mediums respectively, containing 10% FCS, 100
units/ml penicillin and 100 mg/ml streptomycin (Gibco BRL,
Grand Island, NY, USA). After incubation with either PBS,
AdGFP or AdHSP (both at 5610
7 PFU/ml) for 24 hrs, cells were
treated with 20 ng/ml TNFa for 30 minutes (R&D, Minneapolis,
USA). The cells were extracted as previously described [21].
Cytosolic extracts were subjected to immunoprecipitation using a
rabbit polyclonal antibody to Apaf-1 (diluted 1:200), rabbit
polyclonal caspase-8 (diluted 1:200) or to enzymatic activity assay
as described below.
Immunoblot Analysis
30 mg of total protein lysate were separated using 9% SDS-
PAGE. All signals were detected by enhanced chemiluminescence
and quantified by scanning densitometry. Caspases 8, 9, 3 and
Apaf-1 (diluted 1:500) were identified using primary polyclonal
rabbit antibodies (Santa-Cruz Biotechnology Inc., Santa-Cruz, CA,
USA). Hsp70 (diluted 1:1000) was detected with either a mouse
monoclonal or rabbit polyclonal antibody (StressGen Biotechnol-
ogies Corp, Canada). Bcl-2 (diluted 1:1000) was detected with
mouse monoclonal antibody (MBL Inc, Woburn, MA). b-actin
(diluted 1:15,000) was detected with goat antibody (Sigma, St.
Louis, MO). Histone (H1) (diluted 1:1000) was detected with a
mouse monoclonal antibody (Santa-Cruz Biotechnology Inc.,
Santa-Cruz, CA, USA). COX IV (mitochondria loading control)
(diluted 1:1000) was detected with a mouse monoclonal antibody
(abcam,Cambridge,UK).Thesecondaryantibodiesweregoatanti-
rabbit IgG, goat anti mouse IgG or donkey anti goat IgG (Jackson,
Immunoresearch Lab., Inc., West Grove, PA., USA).
Immunoprecipitation
250 mg of cytosolic extract were immunoprecipitated using a
rabbit polyclonal anti-caspase 9, 8 or rabbit polyclonal anti-Apaf-1
(Santa Cruz Biotech Inc), diluted either 1:500 or 1:200. Samples
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Louis, MO, USA and Pierce Inc., USA) were added and the
samples were agitated for two more hours at 4uC and centrifuged
at 14,000 rpm for 5 min at 4uC. The resulting pellet was washed
three times with lysis buffer [21,39], suspended in sample buffer
containing 5 M urea or beta-mercaptoethanol and heated to 60uC
or boiled for 5 min respectively. The resulting mixture was
subjected to immunoblotting as described above.
Immunohistochemistry of lung tissue
Immunostaining was performed as previously described [19,20]
usingprimaryrabbitpolyclonalantibodytomyeloperoxidase (MPO),
(Neomarker,Fremont, CA), diluted 1:100, rabbit polyclonal antibody
to Aquaporin 5 (AQP5) (Almone Inc., Jerusalem, Israel), diluted
1:100 and a primary rabbit antibody directed at the cleaved form of
caspase-3 (CellSignaling Technology Inc. Beverly, MA, USA).MPO
is a marker for neutrophils [40]. For detection we used an anti rabbit
IgG (EnVision System, DAKO, Carpinteria, CA, USA) conjugated
to horseradish peroxidase as previously described [21,41].
Gel FiltrationChromatography(Fractionation bymolecular
weight)
0. 5 ml of cytosolic extracts were loaded onto a Sephacryl S300
filtration column (Amersham Pharmacia- Biotech, Uppsala,
Sweden). The gel filtration buffer contained: 20 mM Tris
(pH 8.0), 0.1 M NaCl and 0.02% NaN3. Proteins were eluted from
the column at a flow rate of 1 ml/min and 1 ml fractions were
collected. The column was calibrated using the following standards:
Thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa),
aldolase (163 kDa), bovine serum albumin (67 kDa), ovoalbumin
(44 kDa) and myoglobulin (17 kDa). Isolated gel filtration chroma-
tography fractions were loaded onto 8% or 9% gels, subjected to
SDS-PAGE and transferred to nitrocellulose membranes.
TUNEL Assay
Fragmented DNA in apoptotic cells was quantified using the
Dead End
TM Fluorometric TUNEL System (Promega Corp.,
Madison, WI, USA) on paraffin-embedded sections. Fluorescein-
12-dUTP-labeled DNA was visualized directly using fluorescence
microscopy. Nuclei were counterstained with DAPI (Vector
Laboratories Inc, Burlingame, CA, USA) [42]. For apoptotic
cells, we examined positive green fluorescent apoptotic nuclei in 20
low power fields/slide at 206 magnification 20 fields per slide
were randomly manually selected by a single observer who was
blinded to the intervention (AdHSP, AdGFP, PBS).
Combined immunoperoxidase or Aquaporin staining and
TUNEL
In order to characterize the apoptotic cells within the septic
lung, a double labeling technique was used. We first stained with a
Chromogen AEC (EnVision System, DAKO, Carpinteria, CA,
USA) method to detect MPO in neutrophils or Aquaporin (AQP5)
in alveolar type I cells and then with TUNEL to indentify
apoptosis. MPO was detected using a primary rabbit polyclonal
antibody (Neomarker, Fremont, CA) diluted 1:100 and a
secondary anti rabbit IgG. AQP5 was detected using a primary
rabbit polyclonal antibody (Almone Inc., Jerusalem, Israel) diluted
1:100 and a secondary anti rabbit IgG. After washing in phosphate
buffered saline (PBS), the TUNEL assay was performed as
previously described [43] as well as the method described above.
Caspase -3 enzymatic activity assay
Caspase-3 enzymatic activity was quantified using a colorimet-
ric activity assay (Chemicon international Inc, USA & Canada).
Briefly, apoptosis was induced in MLE-12 cells using 20 ng/ml
TNFa for 30 minutes. 1610
6 cells were subjected to centrifugation
at 1500 rpm for 10 minutes. Cells were resuspended in cold lysis
buffer, incubated for 10 minutes on ice and centrifuged for
5 minutes at 10,000 g. Supernatants (cytosolic extracts) were
incubated with an assay mixture containing caspase-3 substrate
and assay buffer (final concentration of 16) for 1 hr at 37uC.
Optical density at 405 nm was determined.
Ex-vivo GST-Apaf-1 CARD competitive assay
GST-Apaf-1 CARD plasmid (1–97 aa) was transformed into
BL-21 competent cells. Cells were grown, lysed and incubated
with glutathione beads over night at 4uC followed by incubation
with glutathione reduced buffer, as previously described [21]. The
supernatant was further incubated with Co-immunoprecipitated
lung extracts with Pro-caspase-9 antibody as previously described
[21]. 5 mM ATP and 5 mg/ml of human Cytochrome-C re-
combinant protein were added to the mixture for 5, 10, 20 and
30 minutes at 37uC. Sample buffer was added to the samples, the
samples were boiled for 5 minutes at 95uC, centrifuged and the
supernatants were loaded on 8% SDS-PAGE. Nitrocellulose
membranes were further incubated with Cleaved Caspase-9
antibody.
Statistical analysis
At least three independent samples were evaluated for each
experimental point. Analysis of variance (ANOVA) with Bonfer-
roni’s correction was used to examine differences between and
within groups. The significance level was set at P,0.05.
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